Search research articles
Contact Us
Filters
Showing results (191-200 of 202) with videos related to
Page
of 21
Sort By:
Nature Communications
|
September 11, 2020
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically
Enkhtsetseg Munkhbaatar, Michelle Dietzen, Deepti Agrawal, et al.
Nature Communications
|
March 16, 2024
Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
Celina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro, et al.
Nature Communications
|
August 2, 2023
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
Celina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro, et al.
JCO Precision Oncology
|
February 9, 2022
Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research Experience
Amelie Lier, Roland Penzel, Christoph Heining, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 28, 2022
Gene expression-based prediction of pazopanib efficacy in sarcoma
Christoph E Heilig, Andreas Laßmann, Sadaf S Mughal, et al.
Cancer Cell
|
September 13, 2017
A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development
Yannick Boege, Mohsen Malehmir, Marc E Healy, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?
D William, M Bermúdez, A Kübler, et al.
Cancer Discovery
|
June 11, 2021
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers
Peter Horak, Christoph Heining, Simon Kreutzfeldt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2022
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
A Jahn, A Rump, T J Widmann, et al.
Cell Death and Differentiation
|
September 20, 2014
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
L Galluzzi, J M Bravo-San Pedro, I Vitale, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 202) with videos related to
Sort By:
Page
of 21
Nature Communications
|
September 11, 2020
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically
Enkhtsetseg Munkhbaatar, Michelle Dietzen, Deepti Agrawal, et al.
Nature Communications
|
March 16, 2024
Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
Celina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro, et al.
Nature Communications
|
August 2, 2023
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
Celina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro, et al.
JCO Precision Oncology
|
February 9, 2022
Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research Experience
Amelie Lier, Roland Penzel, Christoph Heining, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 28, 2022
Gene expression-based prediction of pazopanib efficacy in sarcoma
Christoph E Heilig, Andreas Laßmann, Sadaf S Mughal, et al.
Cancer Cell
|
September 13, 2017
A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development
Yannick Boege, Mohsen Malehmir, Marc E Healy, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?
D William, M Bermúdez, A Kübler, et al.
Cancer Discovery
|
June 11, 2021
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers
Peter Horak, Christoph Heining, Simon Kreutzfeldt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2022
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
A Jahn, A Rump, T J Widmann, et al.
Cell Death and Differentiation
|
September 20, 2014
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
L Galluzzi, J M Bravo-San Pedro, I Vitale, et al.
Page
of 21